Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia.
about
Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patientsProphylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patientsLow prevalence of Pneumocystis pneumonia (PCP) but high prevalence of pneumocystis dihydropteroate synthase (dhps) gene mutations in HIV-infected persons in UgandaPneumocystis jirovecii pneumonia in Latin America. A public health problem?Dihydropteroate synthase mutations in Pneumocystis pneumonia: impact of applying different definitions of prophylaxis, mortality endpoints and mutant in a single cohortHigh prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa.Outcomes and duration of Pneumocystis jiroveci pneumonia therapy in infants with severe combined immunodeficiency.Management of patients with HIV in the intensive care unitPneumocystis mediates overexpression of antizyme inhibitor resulting in increased polyamine levels and apoptosis in alveolar macrophages.High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.Pneumocystis jirovecii colonization in chronic pulmonary diseasePneumocystis jiroveci dihydropteroate synthase gene mutations among colonized individuals and Pneumocystis pneumonia patients from Spain.Pneumocystis workshop: 10th anniversary summary.Pneumocystis jirovecii dihydropteroate synthase gene mutations and human immunodeficiency virus-associated Pneumocystis pneumonia.
P2860
Q24193204-E7F649E6-764F-493B-8D28-F84C4F407ED1Q24243871-514FFD6D-A7DE-4BE5-B013-1C157CCBA9CAQ28485240-CEFEC64A-8D03-4477-8485-37826B543C13Q30431684-5E128781-A3CE-4612-BEEA-2AF6B3CC11DCQ33559462-CEF3B52A-207B-4D11-9269-3961637C2AA5Q33909311-723ACF0D-5674-4256-A11F-667864C6927CQ35629437-75D67CA5-DE04-4135-8C62-E33A2B20F97CQ36403151-FE341F1D-DD7B-41D0-94CA-3DCF46268501Q37134470-3B5AFFD7-29C0-4C58-8100-6CEA525910B7Q37612910-6CAB3D74-BA28-4E4F-B6B9-C6020462BE7FQ37890370-066A9DA1-7289-4F07-A753-8A16237FB8C4Q42805368-D3F9E427-BE69-4F05-BEB0-B8C9665D392DQ43145521-84E76F96-55E0-48E5-939F-543B41BE251BQ45409202-1DF6EB0D-A602-421E-A360-1450A0532D1B
P2860
Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia.
@ast
Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia.
@en
type
label
Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia.
@ast
Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia.
@en
prefLabel
Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia.
@ast
Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia.
@en
P2093
P2860
P921
P356
P1476
Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia.
@en
P2093
Charles Poole
Cheryl R Stein
Powel Kazanjian
P2860
P304
P356
10.3201/EID1010.040362
P577
2004-10-01T00:00:00Z